Docusate Sodium
Formulations: - Oral > Liquid: 50 mg per 5 mL; 12.5 mg per 5 mL Oral > Solid > capsule: 100 mg Indications: - Palliative care Source: EML workbook import

Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Oral > Liquid: 50 mg per 5 mL; 12.5 mg per 5 mL Oral > Solid > capsule: 100 mg Indications: - Palliative care Source: EML workbook import
Formulations: - Oral > Liquid: 2 mg per mL Oral > Solid: 0.5 mg; 2 mg; 5 mg Parenteral > General injections > unspecified: 5 mg per mL in 1-mL ampoule - Parenteral > General injections > IM: 5 mg per mL in ampoule Oral > Solid: 2 mg; 5 mg Indications: - Palliative care - Schizophrenia or other primary psychotic disorders Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 20 mg per mL injection Indications: - Palliative care Source: EML workbook import
Formulations: - Local > Topical > Transdermal patch: 1 mg per 72 hours transdermal patch Parenteral > General injections > unspecified: 400 µg per mL injection; 600 µg per mL injection Indications: - Palliative care Source: EML workbook import
Formulations: - Oral > Liquid: 3.3 to 3.4 g per 5 mL oral liquid Indications: - Palliative care Source: EML workbook import
Formulations: - Oral > Solid > dosage form: 2 mg Indications: - Palliative care Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 5 mg per mL in 1 mL ampoule (lactate) Oral > Solid: 2 mg tablet (hydrochloride) Indications: - Parkinson disease Source: EML workbook import
Indications: - Parkinson disease Source: EML workbook import
Formulations: - Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet Indications: - Parkinson disease Source: EML workbook import
Formulations: - Oral > Solid: 300 mg + 25 mg + 800 mg + 160 mg tablet (scored) Indications: - Other specified prophylactic measures Source: EML workbook import
Formulations: - Parenteral > General injections > IM: 300 mg powder and solvent for suspension; 400 mg powder and solvent for suspension Indications: - Schizophrenia or other primary psychotic disorders Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.